MCIVER ZACHARIAH (Chief Medical Officer) sold 10.4% of their position (2.71K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $37.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0002050056-26-000002
Officer· Chief Medical Officer
Since Jan 2025
+127.79K
Net shares
Net buyer
$37.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
130.50K acquired · 2.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.71K
Price / share
$13.73
Trade value
$37.26K
% of position
10.4%
1/2/2026
26K→23.29K
Common Stock
Direct
Shares
+29K
Price / share
—
Trade value
—
% of position
124.5%
1/2/2026
23.29K→52.29K
Total
Net shares
+26.29K
Net value
-$37.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −2.71K | $13.73 | $37.26K | 10.4% | 26K | 23.29K |
| Common Stock Direct | 1/2/2026 | A · Award | +29K | — | — | 124.5% | 23.29K | 52.29K |
| Total | +26.29K | -$37.26K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
101.50K shares
Shares
+101.50K
Strike price
13.65
Held after
101.50K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock101.50K shares | 1/2/2026 | A · Award | +101.50K | 13.65 | — | 101.50K |